Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lana Al-Rashdan

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The American Journal of Cardiology|August 9, 2021
Management Strategies for Atrial Fibrillation and Flutter in Patients with Transthyretin Cardiac AmyloidosisZack Dale, Pranav Chandrashekar, Lana Al-Rashdan, et al.
International Journal of Cardiology|November 29, 2021
Mode of death and outcomes of implantable cardioverter defibrillators in transthyretin amyloid cardiomyopathyZack Dale, Lana Al-Rashdan, Miriam Elman, et al.
Circulation. Genomic and Precision Medicine|August 31, 2021
Prevalence and Outcomes of p.Val142Ile <i>TTR</i> Amyloidosis Cardiomyopathy: A Systematic ReviewPranav Chandrashekar, Laith Alhuneafat, Meghan Mannello, et al.
International Journal of Cardiology|April 19, 2022
Routine ambulatory heart rhythm monitoring for detection of atrial arrhythmias in transthyretin cardiac amyloidosisZack Dale, Pranav Chandrashekar, Lana Al-Rashdan, et al.
ESC Heart Failure|October 28, 2021
Perioperative Amiodarone to Prevent Atrial fibrillation after Septal Myectomy in obstrUctive hypeRtroPHic cardiomyopathyEvan F Shalen, Stephen B Heitner, Lana Al-Rashdan, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The American Journal of Cardiology|August 9, 2021
Management Strategies for Atrial Fibrillation and Flutter in Patients with Transthyretin Cardiac AmyloidosisZack Dale, Pranav Chandrashekar, Lana Al-Rashdan, et al.
International Journal of Cardiology|November 29, 2021
Mode of death and outcomes of implantable cardioverter defibrillators in transthyretin amyloid cardiomyopathyZack Dale, Lana Al-Rashdan, Miriam Elman, et al.
Circulation. Genomic and Precision Medicine|August 31, 2021
Prevalence and Outcomes of p.Val142Ile <i>TTR</i> Amyloidosis Cardiomyopathy: A Systematic ReviewPranav Chandrashekar, Laith Alhuneafat, Meghan Mannello, et al.
International Journal of Cardiology|April 19, 2022
Routine ambulatory heart rhythm monitoring for detection of atrial arrhythmias in transthyretin cardiac amyloidosisZack Dale, Pranav Chandrashekar, Lana Al-Rashdan, et al.
ESC Heart Failure|October 28, 2021
Perioperative Amiodarone to Prevent Atrial fibrillation after Septal Myectomy in obstrUctive hypeRtroPHic cardiomyopathyEvan F Shalen, Stephen B Heitner, Lana Al-Rashdan, et al.
Pageof 1